Tech Center 1600 • Art Units: 1600 1632
This examiner grants 64% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18488859 | TREATMENT OF CANAVAN DISEASE | Final Rejection | CITY OF HOPE |
| 18415477 | ARTIFICIAL NUCLEIC ACID MOLECULES | Final Rejection | CureVac SE |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy